ISOPEUTIC
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Jan 2024)
What this means for you
Registered since 17 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86092768
- Registration number
- 5124619
- Mark type
- Stylized text
- Filed
- 16 Oct 2013
- Published for opposition
- 30 Sept 2014
- Registered
- 17 Jan 2017
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical topical gels and ointments for transdermal delivery of analgesics, anti-inflammatories, antineoplastic agents for the treatment of cancer, muscle relaxants, anaesthetics, peptides for the treatment of skin conditions, proteins for the treatment of wounds, growth factors for the treatment of burns, hormones, substance P antagonists for the prevention of nausea and vomiting, antifungal preparations, antivirals, antibacterial substances for medical purposes, antiobesity drugs, homeopathic agents for the treatment of pain, antianginal medications, hair growth stimulants, hair growth retardants, nutritional supplements, and antimetabolites for the treatment of cancer
Owner
- Gensco Laboratories, LLC, Doral, FL, US
- Gensco Laboratories, LLC, Doral, FL, US
- Gensco Laboratories, LLC, Miramar, FL, US
Prosecution history
- 17 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 13 Jun 2023 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 13 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Dec 2022 — TEAS SECTION 8 & 15 RECEIVED
- 17 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Dec 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Dec 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Nov 2016 — USE AMENDMENT FILED
- 23 Nov 2016 — TEAS STATEMENT OF USE RECEIVED
- 26 May 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED